Summary & Overview
HCPCS L8642: Hallux Implant
HCPCS Level II code L8642 represents a hallux implant, an implantable prosthetic device for the first metatarsophalangeal joint. This code matters nationally as surgical foot and toe implants are part of an evolving area of musculoskeletal care with implications for device coverage, surgical site utilization, and post-procedure durable medical equipment and follow-up services. Payers commonly involved in coverage decisions for L8642 include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will find an overview of the clinical context for hallux implants, typical sites of service, and the payer landscape that shapes coverage and coding practices. The publication summarizes benchmarks where available, highlights relevant policy considerations for payers and providers, and outlines common billing modifiers and coding relationships. Data not available in the input is noted where applicable.
Billing Code Overview
HCPCS Level II code L8642 describes a hallux implant, a medical device used to replace or support the first metatarsophalangeal (big toe) joint. The service type is implantable prosthetic device placement intended to restore joint function, reduce pain, or correct deformity of the hallux.
Typical site of service for procedures involving L8642 is an outpatient surgical setting, such as an ambulatory surgery center or hospital outpatient department.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 55-year-old ambulatory adult with symptomatic hallux rigidus or advanced osteoarthritis of the first metatarsophalangeal joint presenting to an orthopedic foot and ankle clinic. Conservative care (NSAIDs, activity modification, shoe modifications, corticosteroid injection) failed to relieve pain and limit ambulation. The surgeon evaluates radiographs showing joint space narrowing, osteophyte formation, and subchondral sclerosis. The clinical workflow includes preoperative evaluation, informed consent for hallux implant arthroplasty (L8642 describes the implant product), scheduling in an ambulatory surgery center or hospital outpatient department, intraoperative implantation of the hallux prosthesis under regional or general anesthesia, postoperative recovery with weight-bearing as tolerated per implant protocol, and follow-up visits for wound check, radiographic assessment, and rehabilitation. Typical sites of service are the Ambulatory Surgery Center (ASC) or Hospital Outpatient Department for implantation, and an office or outpatient clinic for pre- and postoperative care. Common patient scenario modifiers include bilateral procedures, staged surgeries, surgeon-specific care, or postoperative complications requiring additional services.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
00 | No modifier | Standard reporting when no modifier applies |